{"id":"W4406270195","doi":"10.1016/j.jtha.2024.12.038","title":"Safety and efficacy of valoctocogene roxaparvovec with prophylactic glucocorticoids: 1-year results from the phase 3b, single-arm, open-label GENEr8-3 study","year":2025,"lang":"en","type":"article","venue":"Journal of Thrombosis and Haemostasis","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"BioMarin Pharmaceutical; Novo Nordisk; World Federation of Hemophilia; Sanofi","keywords":"Open label; Medicine; Pharmacology; Internal medicine; Clinical trial","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00484147,0.0009126933,0.001819885,0.0003325221,0.0004507579,0.001276047,0.0006741973,0.001736763,0.002230237],"category_scores_gemma":[0.001833604,0.0003746653,0.001598695,0.0003478797,0.0007951558,0.001198727,0.0003700592,0.003056381,0.0005562031],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008586977,"about_ca_system_score_gemma":0.001085686,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005862296,"about_ca_topic_score_gemma":0.001049464,"domain_scores_codex":[0.9986113,0.0006718667,0.00008630251,0.0001831801,0.0002253401,0.0002219368],"domain_scores_gemma":[0.9975626,0.0004048899,0.000923868,0.0001936767,0.0001888799,0.0007261253],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7974615,0.04475307,0.01336612,0.0008581402,0.002649838,0.000183226,0.0002858644,0.001802461,0.03169033,0.0001884449,0.004086547,0.1026745],"study_design_scores_gemma":[0.3517663,0.5911819,0.04742446,0.00008998847,0.001104748,0.0004418621,0.0001035571,0.001129287,0.003720208,0.0001731,0.002809675,0.00005496511],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9913262,0.004542776,0.0005711165,0.0003475113,0.00007006549,0.0007592019,0.001292225,0.00007672862,0.001014181],"genre_scores_gemma":[0.9925023,0.001560128,0.0008783339,0.0008074493,0.0001678171,0.0008317028,0.002289351,0.00002849674,0.000934493],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00484147,"threshold_uncertainty_score":0.02560449,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1208517844526709,"score_gpt":0.400359249345543,"score_spread":0.279507464892872,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}